CGM
CC icon

Capital Growth Management’s Chemours CC Stock Holding History

Capital Growth Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30,000
Closed -$1.33M – 59
2018
Q2 		$1.33M Buy
+30,000
New +$1.49M 0.07% 48
2017
Q4 		– Sell
-770,000
Closed -$39M – 60
2017
Q3 		$39M Buy
+770,000
New +$36.3M 1.71% 27

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Growth Management's CC Position: Q3 2018 in Review

Capital Growth Management sold out of Chemours (CC) in Q3 2018, closing a stake of 30,000 shares — an estimated $1.33M sold.

Capital Growth Management first reported a position in CC in Q3 2017 and held it in 2 quarters. The position peaked at $39M in Q3 2017. 551 funds tracked by Wall St. Rank hold CC as of Q3 2018.

  • Capital Growth Management reported no remaining Chemours position as of Q3 2018 after selling out during the quarter.
  • Capital Growth Management sold 30,000 Chemours shares in Q3 2018, an estimated $1.33M.
  • Capital Growth Management first reported a position in Chemours in Q3 2017 and held it in 2 quarters.
  • Capital Growth Management's Chemours position peaked at $39M in Q3 2017.
  • 551 funds tracked by Wall St. Rank held Chemours as of Q3 2018.

Based on Capital Growth Management's 13F filing for Q3 2018, filed 9 Nov 2018.